Women’s Health Newsflash: Breast Cancer
Who has time to read it all? Here’s a quick rundown of what you need to know in recent women’s health news. Today’s topic: Breast cancer.
Surgical Site Infections More Common Than Expected Following Breast Procedures
Excerpt: Infections at the incision site occurred in more than 5 percent of patients following breast surgery and cost them more than $4,000 each in hospital-related expenses, according to a new article. …”Patients with surgical site infections had significantly higher hospital costs associated with surgery and during the one-year period after surgery compared with uninfected patients, and they had a significantly longer total length of hospital stay,” the authors write. After adjusting for the type of surgical procedure performed, breast cancer stage and other variables that influence cost, the cost of surgical site infections was $4,091 per patient.” Read more >>>
Further Breakthroughs for Breast Cancer Patients
Excerpt: While drugs such as tamoxifen have been a huge success in treating breast cancer, for a significant proportion of sufferers the drugs either fail to work, or after an initial successful response the patient relapses as the cancer acquires or possesses resistance to the drug. However … researchers have discovered that inhibiting the activity of a certain protein in the cancer could prevent or even reverse the resistance to tamoxifen. The researchers noticed that when breast cancer cells grown in the laboratory develop resistance to tamoxifen, they show a large increase in the activity of a protein known as Src — and by stopping this activity resistance to tamoxifen can be prevented and even reversed. Read more >>>
New Pathway Provides More Clues About BRCA1 Role In Breast Cancer
A breast cancer gene’s newly discovered role in repairing damaged DNA may help explain why women who inherit a mutated copy of the gene are at increased risk for developing both breast and ovarian cancer. The discovery also could lead to more effective therapies for women with and without mutated copies of the BRCA1 gene, according to a study led by Duke University Medical Center researchers. Read more >>>
Findings Point To Molecular ‘Achilles Heel’ For Half Of Breast Cancer Tumors
Researchers at Lombardi Comprehensive Cancer Center at Georgetown University Medical Center have shown why a protein known as cyclin D1 may be the Achilles heel for breast tumors that are estrogen receptor positive (ER+) − which is the most common type of breast cancer. Read more >>>
Don’t forget to enter to win a $50 Target gift card!
Tags: womens health, woman, health, newsflash, health headlines, breast cancer, brca, cyclin D1, tamoxifen resistance, surgical site infection, mastectomy
Related Stories
POSTED IN: Body, Breast cancer, Cancer, Health, New research, Women's Health Newsflash, Women's Issues
.gif)
0 opinions for Women’s Health Newsflash: Breast Cancer
No one has left a comment yet. You know what this means, right? You could be first!
Have an opinion? Leave a comment: